Buscar
Mostrando ítems 1-3 de 3
In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species
(Wiley, 2013)
The strict nutritional requirements of Malassezia species make it difficult to test the
antifungal susceptibility. Treatments of the chronic and recurrent infections associ-
ated with Malassezia spp. are usually ...
La utilidad clínica de los derivados triazólicos en el tratamiento de las infecciones fúngicas
(Sociedad Española de Quimioterapia, 2015)
El tratamiento de las infecciones producidas por hongos se limita al uso de un reducido número de moléculas. Si bien, la anfotericina B aún sigue siendo considerada como el antifún¬gico de referencia, para el tratamiento ...
Combination antifungal therapy : a strategy for the management of invasive fungal infections
(Sociedad Española de Quimioterapia, 2014)
Invasive mycoses have become an important public health
problem as their incidence has increased dramatically in the
last decades, while the discovery of the ideal antifungal agent
has not been yet obtained1-4. The ...